Kathleen Zhang, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Pfizer
    Topic:
    Prostate cancer and cardiovascular disease
    Date added:
    08/22/2022
    Date updated:
    09/05/2024
    Relationship end date:
    06/18/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    BridgeBio Pharma
    Topic:
    Transthyretin cardiac amyloidosis
    Date added:
    08/22/2022
    Date updated:
    09/05/2024
    Relationship end date:
    02/14/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Janssen Pharmaceuticals
    Topic:
    Cardiac amyloidosis
    Date added:
    08/22/2022
    Date updated:
    09/05/2024
    Relationship end date:
    01/01/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Alnylam Pharmaceuticals
    Topic:
    Cardiac amyloidosis
    Date added:
    08/22/2022
    Date updated:
    09/05/2024
    Relationship end date:
    01/01/2022
Return to 234 Cardio-Oncology Conference: "Communication Strategies for Cardio-Oncology Patients: A Palliative Care Perspective" (093022)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.